According to a Reuters article, AmerisourceBergen Corp. will acquire PharMEDium Healthcare Holdings Inc. for $2.58 billion from Clayton, Dubilier & Rice, expanding its business of supplying compounded drugs to hospitals.
Increased regulatory oversight following a fungal meningitis outbreak at a compounding pharmacy in 2012 has escalated the costs for hospitals to produce compounded products internally, boosting demand for large-scale firms such as PharMEDium, the article said.
Read the Reuters article
